摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

aspinolide A

中文名称
——
中文别名
——
英文名称
aspinolide A
英文别名
(2R,4E,6R)-6-hydroxy-2-methyl-2,3,6,7,8,9-hexahydrooxecin-10-one
aspinolide A化学式
CAS
——
化学式
C10H16O3
mdl
——
分子量
184.235
InChiKey
VKDMNNPYTXNZQZ-COKDONQUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    13
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.7
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • ORGANOCATALYTIC PROCESS FOR ASYMMETRIC SYNTHESIS OF DECANOLIDES
    申请人:Council of Scientific and Industrial Research
    公开号:US20150210665A1
    公开(公告)日:2015-07-30
    The present invention discloses organocatalytic process for asymmetric synthesis of highly enantioselective decanolide compounds in high yield with >99% ee. Further, the present invention disclose cost effective, improved organocatalytic process for asymmetric synthesis of highly enantioselective decanolides compounds from non-chiral, cheap, easily available raw materials.
    本发明公开了一种高效的有机催化过程,用于非对称合成高对映选择性的癸内酯化合物,产量高且对映体过量大于99%。此外,本发明还揭示了一种成本效益高、改进的有机催化过程,用于从非手性、便宜且易于获得的原料中非对称合成高对映选择性的癸内酯化合物。
  • Scalable Regioselective and Stereoselective Synthesis of Functionalized (<i>E</i>)-4-Iodobut-3-en-1-ols: Gram-Scale Total Synthesis of Fungal Decanolides and Derivatives
    作者:Alexander M. Sherwood、Samuel E. Williamson、Stephanie N. Johnson、Anil Yilmaz、Victor W. Day、Thomas E. Prisinzano
    DOI:10.1021/acs.joc.7b02324
    日期:2018.1.19
    A reliable protocol to synthesize both racemic and chiral (E)-4-iodobut-3-en-1-ols from aldehydes or epoxides, respectively, containing various aromatic and aliphatic substitutions has been established. The utility of these compounds was then demonstrated by providing access to known fungal decanolides as well as novel aromatic macrocycles. The protocol provided a gram-scale route to (−)-aspinolide
    建立了分别从醛或环氧化物分别包含各种芳族和脂族取代基合成外消旋和手性(E)-4-碘丁-3--3-烯-1-醇的可靠方案。然后,通过提供对已知真菌癸醇化物以及新型芳香族大环化合物的使用,证明了这些化合物的效用。该协议利用催化的Nozaki-Hiyama-Kishi反应在最后一步以65-84%的产率封闭大环内酯,从而为(-)-aspinolide A和(-)-5- epi -aspinolide A提供了克级的途径。
  • Asymmetric synthesis of (+)-stagonolide C and (−)-aspinolide A via organocatalysis
    作者:Anil M. Shelke、Varun Rawat、Gurunath Suryavanshi、Arumugam Sudalai
    DOI:10.1016/j.tetasy.2012.10.007
    日期:2012.12
    A new enantioselective synthesis of two important fungal metabolites, (+)-stagonolide C and ()-aspinolide A, has been described from readily available raw materials. Proline catalyzed asymmetric α-aminooxylation and Jorgensen’s epoxidation of aldehydes are the key reactions employed in the introduction of chirality. The formation of the 10-membered lactone core structure was finally accomplished via
    已经从容易获得的原料中描述了两种重要的真菌代谢物,(+)-斯塔格奈德C和(-)-aspinolide A的新的对映选择性合成。脯氨酸催化的不对称α-氨氧基化和约根森的醛环氧化是引入手性的关键反应。最终通过Steglich酯化反应和闭环易位反应完成了10元内酯核心结构的形成。
  • Novel Synthesis of Stagonolide-F, Putaminoxin and Aspinolide-A
    作者:Ahmed Kamal、Papagari Venkat Reddy、Moku Balakrishna、Singaraboina Prabhakar
    DOI:10.2174/157017811794697502
    日期:2011.2.1
    Novel synthesis of putaminoxin, stagonolide-F and aspinolide-A have been achieved by utilizing (S) and (R)- malic acid. The key feature of the synthetic strategy includes Horner-Wittig olefination, double bond reduction and Steglich esterification. Olefinic acid for putaminoxin and stagonolide-F was prepared from (S)-malic acid whereas olefinic acid for aspinolide-A was prepared from (R)-malic acid and olefinic alcohols for putaminoxin, stagonolide-F and aspinolide-A were prepared by using Browns asymmetric allylboration.
    通过利用(S)和(R)-苹果酸,实现了普他米诺辛、芪内酯-F 和芪内酯-A 的新合成。合成策略的主要特点包括霍纳-维蒂希烯化、双键还原和斯特利希酯化。使用布朗不对称烯丙基硼化法制备了普他米诺辛和拮抗内酯-F 的烯烃酸,而使用(R)-苹果酸制备了阿斯匹灵-A 的烯烃酸,并制备了普他米诺辛、拮抗内酯-F 和阿斯匹灵-A 的烯烃醇。
  • First asymmetric total synthesis of aspinolide A
    作者:Partha Sarathi Chowdhury、Priti Gupta、Pradeep Kumar
    DOI:10.1016/j.tetlet.2009.09.151
    日期:2009.12
    The first total synthesis of aspinolide A has been achieved using ring-closing metathesis as a key step. The stereogenic centers were generated by means of hydrolytic kinetic resolution (HKR) of racemic epoxides.
    Aspinolide A的第一个全合成方法是使用闭环复分解作为关键步骤。立体异构中心是通过外消旋环氧化物的水解动力学拆分(HKR)生成的。
查看更多

同类化合物

胰岛素原(cattle),29-[N6-[[2-(甲磺酰)乙氧基]羰基]-L-赖氨酸]-59-[N6-[[2-(甲磺酰)乙氧基]羰基]-L-赖氨酸]-(9CI) 十氢-2,7-苯并二氧杂环癸烷-3,6-二酮 二环<3.3.0>-2-氧杂-5-(2-丙烯基)-1-辛烯 乙烯邻苯二甲酸酯 [(E,1R)-1-[(2R,4Z,7S,8R)-7-溴-8-乙基-3,6,7,8-四氢-2H-氧杂环辛三烯-2-基]己-3-烯-5-炔基]乙酸酯 [(2R,3S,4E,6R,7S)-6,7-二羟基-2-甲基-10-氧代-2,3,6,7,8,9-六氢氧杂环辛三烯-3-基] (E)-丁-2-烯酸酯 6,7-二氢-5aH-氧杂环丁烷并[3,2-d][1,3]苯并二氧戊环 5-氧杂-10-氮杂三环[5.3.1.03,8]十一碳-1(10),2,6,8-四烯 3-氧杂二环[3.3.1]壬-6-烯-9-酮 3,4,5,6-四氢-2,7-苯并二氧杂环癸烷e-1,8-二酮 10-(乙酰氧基)-4,5,6,7-四氢-2H-1-苯并氧杂环辛三烯-2,8(3H)-二酮 1-(2,3,4,5-四氢-1,6-苯并二噁辛英-8-基)丙烷-1-酮 1,2-环己烷二甲酸1-甲基-1,2-乙二基酯 (S)-5-烯丙基-2-氧杂双环[3.3.0]辛-8-烯 (7Z)-2-(3-溴丙-1,2-二烯基)-5-(1-溴丙基)-3,3a,5,6,9,9a-六氢-2H-呋喃并[3,2-b]氧杂环辛三烯 (7E)-4,7-二羟基-10-甲基-3,4,5,6,9,10-六氢氧杂环辛三烯-2-酮 (6Z)-10-甲基-3,4,5,8,9,10-六氢-2H-氧杂环辛三烯-2-酮 (5Z,8S)-3-氯-2-[(E)-戊-2-烯-4-炔基]-8-[(E)-丙-1-烯基]-3,4,7,8-四氢-2H-氧杂环辛三烯 (4Z)-3,6-二氢-2,7-苯并二氧杂环癸烷e-1,8-二酮 (4S,5Z,7S,8S,10R)-4,7,8-三羟基-10-甲基-3,4,7,8,9,10-六氢氧杂环辛三烯-2-酮 (4R,5R,6Z,8S,10R)-4,5,8-三羟基-10-甲基-3,4,5,8,9,10-六氢氧杂环辛三烯-2-酮 (2R,5Z)-8a-[(R)-1-溴丙基]-3a-氯-3,4,7,8-四氢-2a-[(Z)-2-戊烯-4-炔基]-2H-氧杂环辛三烯 1,3,3a,6a-tetrahydro-5-pentyl-4H-cyclopentafuran-4-one trans-1-oxacyclodec-7-ene-2-one 2-epi-herbarumin II (RS)-5-methoxy-2,3,5,6-tetrahydro-8H-benzo[1,4,7]trioxecin β-heptenolactone stagonolide-E fumaric acid butanediyl ester aspinolide A (3R,4R,9S,10R,Z)-4,9-dihydroxy-3-methyl-10-pentyl-3,4,7,8,9,10-hexahydro-2H-oxecin-2-one prelaureatin 8-acetyl-4,4-dimethyl-2,6-dioxo-9-(2-methylpropyl)-2,3,4,5,6,8-hexahydrooxocino[2,3-c]pyrrole 5,6-benzo-2,3-diethoxy-4-oxo-2-hepten-7-olide 3,4,5,6-tetrahydro-oxocin-2-one (Z)-3-butyl-5,6,7,8-tetrahydro-2H-oxocin-2-one presaccharothriolide X 1-{2-[4,5-dihydro-1H-2-benzoxocin-(6Z)-ylidenemethyl]-allyl}-piperidine (R,Z)-8-(methoxymethoxy)-2,2,6,9-tetramethyl-5,6-dihydro-2H-benzo[b]oxocine 5-hydroxy-7R,11-heliannan-10-one 8-methoxy-2,2,6,9-tetramethyl-2H-1-benzoxocin-3(4H)-one 8-methoxy-2,2,6,9-tetramethyl-3,4,5,6-tetrahydro-2H-1-benzoxocin-3-ol (4S,5Z,10R)-4-hydroxy-10-methyl-3,4,7,8,9,10-hexahydro-2H-oxecin-2-one (4R)-9,11-bis(benzyloxy)-4-methyl-4,5,6,7-tetrahydro-1H-benzo[d]-oxecine-2,8-dione ethyl (4Z)-4-methyl-7,8-dihydro-1,3,6-trioxocine-5-carboxylate 4-hydroxy-10-(2-hydroxyethyl)-1,2-dihydro-4,12a-methanooxocino[4,5-b][1,4]benzodioxin-5-one 4-hydroxy-9-(2-hydroxyethyl)-1,2-dihydro-4,12a-methanooxocino[4,5-b][1,4]benzodioxin-5-one (7R,9R,5E)-7-hydroxy-9-propylnon-5-en-9-olide (6S,7R,9R)-6,7-dihydroxy-9-propylnon-4-eno-9-lactone 7-[2-(3,5-Dichloro-N-oxo-pyridin-4-yl)-1-oxoethyl]-10-methoxy-2,3,4,5-tetrahydro-1,6-benzodioxocine